FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI
Bahasa
en
Abstrak
ABSTRACT The COVID-19 pandemic has made prevention procedures against the rapidly spreading infection a top priority. Inactivated COVID-19 vaccines have been developed and authorized for use in some countries including Indonesia, where the Sinovac vaccine has been distributed to health care workers and the elderly. There have been no reports of herpes zoster reactivation after the Sinovac vaccine in Indonesia yet. Advanced age may be a risk factor in reduction of cell-mediated immunity that related to VZV reactivation.However, this article reports an unusual case of varicella zoster virus (VZV) reactivation in a patient who received the COVID-19 vaccine. This is the first case of VZV reactivation following Sinovac COVIDâ€19 vaccination. It is very difficult to establish a straightforward relationship between herpes zoster and inactivated COVIDâ€19 vaccine, immune dysregulation created by the vaccine may play a role in the reactivation of latent VZV infection in the current case. There is a need for further review and studies in the future.
Jaringan kolaborasi para penulis
2 penulis ·
1 tautan kepenulisan bersama
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
Afiliasi tidak diketahui
Organisasi berbeda
Organisasi sama
Afiliasi tidak diketahui
Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulis
Organisasi
Artikel bersama
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.